FDA Seeks Public Input To Develop Guidance For Nanotechnology In Pharmaceuticals
This article was originally published in The Pink Sheet Daily
Executive Summary
Sept. 8 public meeting requests input on safety, efficacy points to consider for using nanotech in drugs, biologics.